Categories: All CategoriesCorporateProductsPipelineFinancial Feb 23, 2021Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation PlanFinancialFeb 18, 2021Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth InitiativesCorporateFeb 16, 2021Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021FinancialFeb 12, 2021New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate CancerPipelineFeb 11, 2021Myriad Genetics to Participate in Multiple Upcoming Health and Technology ConferencesCorporateFeb 08, 2021GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood LevelsProductsFeb 02, 2021Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid ArthritisProductsJan 19, 2021Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in JapanProductsJan 11, 2021Myriad Genetics Forms Strategic Partnership with Illumina in OncologyProductsJan 08, 2021Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®ProductsJan 05, 2021Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International OperationsCorporateJan 04, 2021Myriad Genetics CEO Paul J. Diaz to Present at 39th Annual J.P. Morgan Healthcare ConferenceCorporateDec 11, 2020New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene MutationsPipelineNov 17, 2020Suffering in Silence: Two-Thirds of Older Adults Say They Won’t Treat Their DepressionProductsNov 16, 2020Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and ChinaPipeline Next page